CN109966387A - 一种调养五脏和养心安神的配方及制备方法 - Google Patents
一种调养五脏和养心安神的配方及制备方法 Download PDFInfo
- Publication number
- CN109966387A CN109966387A CN201910250934.3A CN201910250934A CN109966387A CN 109966387 A CN109966387 A CN 109966387A CN 201910250934 A CN201910250934 A CN 201910250934A CN 109966387 A CN109966387 A CN 109966387A
- Authority
- CN
- China
- Prior art keywords
- powder
- tranquilization
- mental
- formula
- internal organs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000001835 viscera Anatomy 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000009472 formulation Methods 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 189
- 239000000203 mixture Substances 0.000 claims abstract description 31
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 24
- 241000894006 Bacteria Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 18
- 241001145025 Saussurea involucrata Species 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 15
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 15
- 108010010803 Gelatin Proteins 0.000 claims abstract description 14
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 14
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 14
- 229920000159 gelatin Polymers 0.000 claims abstract description 14
- 239000008273 gelatin Substances 0.000 claims abstract description 14
- 235000019322 gelatine Nutrition 0.000 claims abstract description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000723418 Carya Species 0.000 claims abstract description 11
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 11
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 11
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- 235000005638 Austrian pine Nutrition 0.000 claims abstract description 10
- 235000008565 Pinus banksiana Nutrition 0.000 claims abstract description 10
- 235000013264 Pinus jeffreyi Nutrition 0.000 claims abstract description 10
- 235000008578 Pinus strobus Nutrition 0.000 claims abstract description 10
- 235000008585 Pinus thunbergii Nutrition 0.000 claims abstract description 10
- 235000014030 Podocarpus spicatus Nutrition 0.000 claims abstract description 10
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 claims abstract description 10
- 244000019397 Pinus jeffreyi Species 0.000 claims abstract description 9
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 19
- 241000208340 Araliaceae Species 0.000 claims description 16
- 241000121220 Tricholoma matsutake Species 0.000 claims description 12
- 241000272503 Sparassis radicata Species 0.000 claims description 9
- 244000060234 Gmelina philippensis Species 0.000 claims description 7
- 241000577951 Hydnum Species 0.000 claims description 7
- 229940046536 tree pollen allergenic extract Drugs 0.000 claims description 6
- 241000222684 Grifola Species 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 18
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 230000001151 other effect Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 230000006870 function Effects 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000003471 anti-radiation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000011132 hemopoiesis Effects 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000382353 Pupa Species 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 240000006698 Spigelia anthelmia Species 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 241000609666 Tuber aestivum Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- -1 for example Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 230000009758 senescence Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 2
- 240000000588 Hericium erinaceus Species 0.000 description 2
- 235000007328 Hericium erinaceus Nutrition 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010049771 Shock haemorrhagic Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940061641 androsterone Drugs 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000628799 Brachybotrys paridiformis Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020466 Hunger Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 244000251141 Podocarpus spicatus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Developmental Biology & Embryology (AREA)
Abstract
本发明公开了一种调养五脏和养心安神的配方及制备方法,每袋5g配方中包括以下重量原料:山药粉0.1‑2g、枸杞粉0.1‑2g、茯苓粉0.1‑2g、葛根粉0.1‑2g、洛神花粉0.1‑2g、雪莲培养物0.001‑0.01g、沙棘粉0.1‑2g、蛹虫草粉0.01‑0.1g、陈皮粉0.01‑0.1g、阿胶粉0.01‑0.1g、人参水提粉0.01‑0.1g、短梗五加粉0.1‑2g、食用菌混合粉(黑松露、羊肚菌等)0.001‑2g。本发明以多种药食同源的动植物为原料,经合理配伍,科学配比而成,具有温肾补血、调养五脏、养心安神、增强免疫力等功效。长期食用,可有效防治类风湿性关节炎等自身免疫性疾病。
Description
技术领域
本发明涉及食品技术领域,特别涉及一种调养五脏和养心安神的配方及制备方法。
背景技术
风湿类疾病如风湿性关节炎、类风湿性关节炎、风湿颈肩腰腿痛、慢性腰疼、肌肉劳损、骨质增生等均为内科临床的常见病和多发病,也是长期困扰人体健康的慢性疾病,该类疾病一般由于免疫失调所致。患者轻则关节红肿、行动受限、疼痛难忍,重则关节僵直、肌肉萎缩、卧床不起。中医理论认为,风湿、类风湿、慢性腰疼、肌肉劳损、骨质增生等,是因为风寒湿邪等痹毒淤积经络、导致经络於阻、血循不畅所致。由于此类症患不易手术,至于十分困难,因而被列为世界性的疑难杂症。目前国内外用于治疗风湿类疾病的传统药物主要以镇疼消炎为主,通过抑制前列腺素酶来缓解疼痛,但它们的药效均只能做一时的消炎止痛,难以从根本上治愈病症,长期用药,不仅使患者对药物有依赖性,而且会引起胃肠粘膜溃疡糜烂,因而也不能为患者真正解除身心之苦。
发明内容
针对现有技术的不足,本发明的目的在于提供一种调养五脏和养心安神的配方,具有温肾补血、调养五脏、养心安神、增强免疫力的作用,能够从根本上改善病痛。
为了达到上述目的,本发明的技术方案为:
一种调养五脏和养心安神的配方,每袋5g配方中包括以下重量原料:山药粉0.1-2g、枸杞粉0.1-2g、茯苓粉0.1-2g、葛根粉0.1-2g、洛神花粉0.1-2g、雪莲培养物0.001-0.01g、沙棘粉0.1-2g、蛹虫草粉0.01-0.1g、陈皮粉0.01-0.1g、阿胶粉0.01-0.1g、人参水提粉0.01-0.1g、短梗五加粉0.1-2g、食用菌混合粉0.001-2g。
优选的,每袋5g配方中包括以下重量原料:山药粉0.5-1.5g、枸杞粉0.5-1.5g、茯苓粉0.5-1.5g、葛根粉0.5-1.5g、洛神花粉0.5-1.5g、雪莲培养物0.005-0.01g、沙棘粉0.5-1.5g、蛹虫草粉0.02-0.1g、陈皮粉0.02-0.1g、阿胶粉0.02-0.1g、人参水提粉0.02-0.1g、短梗五加粉0.2-1.5g、食用菌混合粉0.005-1.5g。
优选的,每袋5g配方中包括以下重量原料:山药粉0.5g、枸杞粉0.5g、茯苓粉0.5g、葛根粉0.5g、洛神花粉0.5g、雪莲培养物0.01g、沙棘粉0.5g、蛹虫草粉0.03g、陈皮粉0.02g、阿胶粉0.02g、人参水提粉0.02g、短梗五加粉1g、食用菌混合粉0.9g。
优选的,所述食用菌混合粉由以下重量原料组成:猴头菇粉0.1-2g、蛹虫草粉0.01-0.1g、香菇粉0.001-0.01g、灰树花粉0.001-0.01g、绣球菌粉0.001-0.01g、羊肚菌粉0.001-0.01g、松茸粉0.001-0.01g、黑松露粉0.001-0.01g。
优选的,所述食用菌混合粉由以下重量原料组成:猴头菇粉1g、蛹虫草粉0.05g、香菇粉0.005g、灰树花粉0.005g、绣球菌粉0.005g、羊肚菌粉0.005g、松茸粉0.005g、黑松露粉0.005g。
本发明配方中的茯苓可以使用茯神代替,陈皮可以使用橘红代替,短梗五加可以使用刺五加代替。
本发明配方可以按照本领域的常规制剂技术,制备成常用的食用剂型,例如,粉剂、液体、膏剂等。
本发明配方在制成食用剂型时,根据需要还可以加入赋性剂、防腐剂、甜味剂等组分;本发明配方优选制备成粉剂。
本发明还提供了一种调养五脏和养心安神的配方的制备方法:将山药粉、枸杞粉、茯苓粉、葛根粉、洛神花粉、雪莲培养物、沙棘粉、蛹虫草粉、陈皮粉、阿胶粉、人参水提粉、短梗五加粉、食用菌混合粉充分混合均匀,装袋即可。
本发明配方中各成分的功效如下:
山药:性平,味甘。归脾经、肺经、肾经。具有补脾养胃、生津益肺、补肾涩精的功效。用治脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴等。现代药理试验结果表明,山药有促进骨折愈合,降血糖,增强免疫功能,增强消化系统功能等作用。
枸杞:性平,味甘。归肝经、肾经。具有滋补肝肾、益精明目的功效。药理研究表明,枸杞增强免疫功能、延缓衰老、抗肿瘤、降血脂、保肝、促进造血功能、抗遗传损伤、降血糖、降血压、抑制心脏及兴奋肠道等拟胆碱作用、增强小鼠的耐缺氧能力及延长其游泳时间。
茯苓:性平,味甘、淡。归心经、肺经、脾经、肾经。具有利水渗湿、健脾宁心的功效。用治水肿尿少、痰饮眩悸、脾虚食少、便溏泄泻、心神不安、惊悸失眠。药理实验表明,茯苓具有利尿、抗菌作用,能提高机体的免疫能力。此外,还有降低血糖、降低胃酸、增强离体心脏心缩等作用。
葛根:性凉,味甘、辛。归脾经、胃经。具有解肌退热、生津、透疹、升阳止泻的功效。用治伤寒、温热头痛项强、烦热消渴、泄泻、痢疾、癍疹不透、高血压、心绞痛、耳聋等。药理实验表明,葛根具有p-受体阻断剂作用,是心血管作用的基础;具有明显的解热作用;可收缩或舒张平滑肌;还具有扩张冠状动脉血管和脑血管,增加冠状动脉血流量和脑血流量,降低心肌耗氧量,增加氧供应,降低血压、降血糖和解除肠管痉挛等作用。
洛神花:洛神花又名山茄子等,它具有食用和药用的双重性。洛神花其味酸、性寒,有益于调节和平衡血脂,增进钙质吸收,促进儿童发育,促进消化等。具有清热解暑、利尿降压、养颜消斑、解毒、解酒等功效。还有活血补血、养颜美容的功能。现代研究表明洛神花含有原儿茶酸、异黄酮素以及丰富的氨基酸、维生素等化学成分,能降低胆固醇和甘油三脂、抑制低密度脂蛋白的氧化、抑制血小板的凝集、降低血栓的形成、减少动脉粥状硬化,可有效地预防心血管疾病的发生。
沙棘:性温,味酸、涩。归脾经、胃经、肺经、心经。具有祛痰止咳、消食化滞、活血散瘀的功效。用治咳嗽痰多、消化不良、食积腹痛、瘀血经闭、跌打瘀肿。研究还证明,有消炎、抗放射损伤、抗肿瘤、抗衰老、抗风湿和抗病毒等作用。药理实验表明,沙棘具有降脂作用、止咳祛痰作用;能调整消化功能,促进溃疡愈合;能增强免疫功能;抗肿瘤;改善心血管系统功能;促进造血功能;降低全血黏度;抑制血小板聚集;降低血清总胆固醇,升高血清高密度脂蛋白胆固醇和肝脏总胆固醇;抑制试验性血栓的形成;保肝;抗胃溃疡;抗氧化;抗炎;增加网状内皮系统的吞噬功能;抗过敏。
陈皮:味辛、味苦,性温。归脾经、肺经。具有理气开胃,燥湿化痰,治脾胃病的功效。用治胸脘胀满、食少呕吐、咳嗽痰多。药理实验表明,陈皮调整消化系统;兴奋心脏,使心肌收缩力增强,剂量过大可抑制心率,又可使冠脉流量增加;对高脂饮食引起的动脉硬化有一定的预防作用;平喘祛痰;使肾血管收缩,使尿量减少;抑制离体子宫,高浓度可松弛子宫;增强免疫功能;抗炎;缩短出血及凝血时间;能促进唾液、胃液等消化液分泌和消除肠内积气。
阿胶:性平,味甘。归肺经、肝经、肾经。具有补血滋阴、润燥、止血的功效。用于血虚萎黄、眩晕心悸、肌痿无力、心烦不眠、虚风内动、肺燥咳嗽、劳嗽咯血、吐血尿血、便血崩漏、妊娠胎漏。药理实验表明,阿胶有促进造血功能、抗辐射损伤作用,能提高耐缺氧、耐寒冷、抗疲劳能力及提高免疫力;促进凝血,增加钙的摄入量,对肌肉萎缩有预防和改善作用;有抗休克、利尿消肿作用;有增加智力、加速生长发育、延缓衰老等作用。
人参:性温,味甘、微苦。归心经、肺经、脾经、肾经。具有大补元气、复脉固脱、补脾益肺、生津安神的功效。用治体虚欲脱、气短喘促、自汗肢冷、精神倦怠、食少吐泻、气虚作喘或久咳、津亏口渴、消渴、失眠多梦、惊悸健忘、阳痿、尿频、一切气血津液不足之症。药理实验表明,人参调节中枢神经系统的生理功能,提高机体免疫功能,强心、抗休克,保护和刺激骨髓的造血功能,增加肾上腺皮质激素分泌,调整血糖水平,显著抑制胆固醇的吸收,抗肿瘤,延缓衰老,加强机体的适应性,其提取物能明显促进大鼠器官核酸和蛋白质的合成。
短梗五加:短梗五加为五加科五加属植物,别名五加参、刺拐棒,主要分布在东北地区及河北、山西、河南等地。其作用特点与人参基本相同,具有免疫调节、抗肿瘤、抗衰老、抗辐射、抗损伤及抗疲劳等多种保健功效。
猴头菇:性平、味甘。利五脏,助消化;具有健胃,补虚,抗癌,益肾精之功效;主治食少便溏、胃及十二指肠溃疡、浅表性胃炎、神经衰弱、食道癌、胃癌、眩晕、阳痿等病症。并对治疗肠癌有辅助作用。年老体弱者食用猴头菇,有滋补强身的作用。
蛹虫草:蛹虫草含有虫草素、虫草酸、腺苷、虫草多糖、麦角甾醇、超氧化物歧化酶、硒等活性成分;其中,虫草素具有抗病毒、抗菌、明显抑制肿瘤生长、干扰人体RNA及DNA的合成等功效;虫草酸具有预防治疗脑血栓、脑溢血、肾功能衰竭,利尿等功效;腺苷具有抗病毒、抗菌,预防治疗脑血栓、脑溢血,抑制血小板积聚,防止血栓形成等功效;虫草多糖具有提高免疫力,延缓衰老,祛风、驱寒、除湿,扶正固本,保护心脏、肝脏,抗痉等功效;麦角甾醇具有抗癌、抗衰、减毒等功效;超氧化物歧化酶具有抑制或消除催人衰老的超氧自由基形成及抗癌、抗衰、减毒等功效;硒具有增强人体免疫能力等功效。
香菇:具有高蛋白、低脂肪、多糖、多种氨基酸和多种维生素。香菇多糖可提高小鼠腹腔巨噬细胞的吞噬功能,还可促进T淋巴细胞的产生,并提高T淋巴细胞的杀伤活性。实验证明,香菇中还含有一种抗病毒的干扰素诱发剂,能提高人体抗病能力,可预防流行性感冒等症。香菇具有和胃、健脾、补气益肾的功效,可治久病气虚、食欲不振等病症。
灰树花:性平、味甘。益气健脾;补虚扶正。主脾虚气弱;体倦乏力;神疲懒言;饮食减少;食后腹胀。
绣球菌:绣球菌含有大量β葡聚糖,β型葡聚糖是一种生物活性物质,经医学研究证实,具有免疫调节、抗肿瘤、抗炎、抗病毒、抗氧化、抗辐射、降血糖、降血脂、保肝等多种功能。据测定,绣球菌中超氧化物歧化酶的含量位居各种食用菌之首,能有效清除体内的自由基,防止活性氧对机体的伤害,具有抗氧化、抗衰老的作用。
羊肚菌:羊肚菌的营养相当丰富,据测定,羊肚菌含粗蛋白20%、粗脂肪26%、碳水化合物38.1%,还含有多种氨基酸,特别是谷氨酸含量高达1.76%。因此,有人认为是“十分好的蛋白质来源”。
松茸:松茸含有18种氨基酸、14种人体必需微量元素、49种活性营养物质、5种不饱和脂肪酸、8种维生素、2种糖蛋白、丰富的膳食纤维和多种活性酶,另含有双链松茸多糖、松茸多肽和松茸醇,是世界上最珍贵的天然药用菌类。松茸的营养价值和药用价值极高。现代医学表明,松茸具有提高免疫力、抗癌抗肿瘤、治疗糖尿病及心血管疾病、抗衰老养颜、促肠胃保肝脏等多种功效。
黑松露:黑松露含有丰富的蛋白质、18种氨基酸(包括人体不能合成的8种必需氨基酸)、不饱和脂肪酸、多种维生素、锌、锰、铁、钙、磷、硒等必需微量元素,以及鞘脂类、脑苷脂、神经酰胺、三萜、雄性酮、腺苷、松露酸、甾醇、松露多糖、松露多肽等大量的代谢产物,具有极高的营养保健价值。其中雄性酮有助阳、调理内分泌的显著功效;鞘脂类化合物在防止老年痴呆、动脉粥样硬化以及抗肿瘤细胞毒性方面有明显活性;多糖、多肽、三萜具有增强免疫力、抗衰老、抗疲劳等作用,可用于保健养身。
雪莲培养物:雪莲培养物是选取雪莲愈伤组织做为继代种子,通过细胞培养技术继代培养获得。雪莲培养物含有丰富的蛋白质和氨基酸,可调节人体酸碱度,含高量多酚类、黄酮类及雪莲多糖等成分,比原始植株拥有更高的效性成分,可促进肌肤胶原蛋白产生,同时抑制胶原破坏。研究表明,雪莲培养物不仅含有与天然雪莲相近的活性成分,且具有与之相当多方面的药理活性。其主要药理作用镇痛、抗炎、抗风湿;抑制血小板聚集、降血脂、改善血液循环;对免疫系统具有调节作用;同时还有抗氧化、抗辐射、和抗疲劳等多方面作用
与现有技术相比,本发明具有如下有益效果:
(1)本发明以多种药食同源的动植物为原料,经合理配伍,科学配比而成。其中,食用菌混合粉精选8种珍贵的食用菌混合而成,营养丰富,可全面补充人体所需营养,具有大补元气、补气健脾、补血活血,散寒除湿、清热解毒、凉血消肿,消炎止痛、活血散瘀、调养五脏、养心安神,提高机体免疫力,改善关节功能,修复病损关节的功效,达到“扶正”、“祛邪”、“通络”、“改善”的目的。长期食用,可有效防治风湿性关节炎、类风湿性关节炎、系统性红斑狼疮、皮肌炎、硬皮病、干燥综合征等自身免疫性疾病。
(2)本发明配方中原料均经过超微破壁粉碎成粉,能最大限度地保留原料的营养成分,保证了原料成分的完整性,既避免了造成原料浪费,节省原料,提高利用率,也有利于制成所需的高质量产品;同时,超微破壁粉碎后产品的粒度更加微小,不仅改善了食用品质,口感更佳,也易于被人体肠胃直接吸收,最大限度地发挥其功效,并充分利用。
具体实施方式
下面对本发明的具体实施方式作进一步说明。在此需要说明的是,对于这些实施方式的说明用于帮助理解本发明,但并不构成对本发明的限定。此外,下面所描述的本发明各个实施方式中所涉及的技术特征只要彼此之间未构成冲突就可以相互组合。
实施例1
一种调养五脏和养心安神的配方,每袋5g配方中包括以下重量原料:山药粉0.5g、枸杞粉0.5g、茯苓粉0.5g、葛根粉0.5g、洛神花粉0.5g、雪莲培养物0.01g、沙棘粉0.5g、蛹虫草粉0.03g、陈皮粉0.02g、阿胶粉0.02g、人参水提粉0.02g、短梗五加粉1g、食用菌混合粉0.9g;制备方法为将上述组分充分混合均匀,装袋即可。
上述食用菌混合粉由猴头菇粉、蛹虫草粉、香菇粉、灰树花粉、绣球菌粉、羊肚菌粉、松茸粉、黑松露粉混合组成。
实施例2
一种调养五脏和养心安神的配方,每袋5g配方中包括以下重量原料:山药粉0.5g、枸杞粉0.5g、茯苓粉0.5g、葛根粉0.5g、洛神花粉0.5g、雪莲培养物0.01g、沙棘粉0.5g、蛹虫草粉0.02g、陈皮粉0.02g、阿胶粉0.03g、人参水提粉0.02g、短梗五加粉0.5g、食用菌混合粉1.4g;制备方法为将上述组分充分混合均匀,装袋即可。
上述食用菌混合粉由猴头菇粉、蛹虫草粉、香菇粉、灰树花粉、绣球菌粉、羊肚菌粉、松茸粉、黑松露粉混合组成。
实施例3
一种调养五脏和养心安神的配方,每袋5g配方中包括以下重量原料:山药粉0.5g、枸杞粉0.5g、茯苓粉0.5g、葛根粉0.5g、洛神花粉0.5g、雪莲培养物0.01g、沙棘粉0.5g、蛹虫草粉0.02g、陈皮粉0.02g、阿胶粉0.03g、人参水提粉0.02g、短梗五加粉0.9g、食用菌混合粉1g;制备方法为将上述组分充分混合均匀,装袋即可。
上述食用菌混合粉由猴头菇粉、蛹虫草粉、香菇粉、灰树花粉、绣球菌粉、羊肚菌粉、松茸粉、黑松露粉混合组成。
以上对本发明的实施方式作了详细说明,但本发明不限于所描述的实施方式。对于本领域的技术人员而言,在不脱离本发明原理和精神的情况下,对这些实施方式进行多种变化、修改、替换和变型,仍落入本发明的保护范围内。
Claims (6)
1.一种调养五脏和养心安神的配方,其特征在于:每袋5g配方中包括以下重量原料:山药粉0.1-2g、枸杞粉0.1-2g、茯苓粉0.1-2g、葛根粉0.1-2g、洛神花粉0.1-2g、雪莲培养物0.001-0.01g、沙棘粉0.1-2g、蛹虫草粉0.01-0.1g、陈皮粉0.01-0.1g、阿胶粉0.01-0.1g、人参水提粉0.01-0.1g、短梗五加粉0.1-2g、食用菌混合粉0.001-2g。
2.根据权利要求1所述的调养五脏和养心安神的配方,其特征在于:每袋5g配方中包括以下重量原料:山药粉0.5-1.5g、枸杞粉0.5-1.5g、茯苓粉0.5-1.5g、葛根粉0.5-1.5g、洛神花粉0.5-1.5g、雪莲培养物0.005-0.01g、沙棘粉0.5-1.5g、蛹虫草粉0.02-0.1g、陈皮粉0.02-0.1g、阿胶粉0.02-0.1g、人参水提粉0.02-0.1g、短梗五加粉0.2-1.5g、食用菌混合粉0.005-1.5g。
3.根据权利要求2所述的调养五脏和养心安神的配方,其特征在于:每袋5g配方中包括以下重量原料:山药粉0.5g、枸杞粉0.5g、茯苓粉0.5g、葛根粉0.5g、洛神花粉0.5g、雪莲培养物0.01g、沙棘粉0.5g、蛹虫草粉0.03g、陈皮粉0.02g、阿胶粉0.02g、人参水提粉0.02g、短梗五加粉1g、食用菌混合粉0.9g。
4.根据权利要求1所述的调养五脏和养心安神的配方,其特征在于:所述食用菌混合粉由以下重量原料组成:猴头菇粉0.1-2g、蛹虫草粉0.01-0.1g、香菇粉0.001-0.01g、灰树花粉0.001-0.01g、绣球菌粉0.001-0.01g、羊肚菌粉0.001-0.01g、松茸粉0.001-0.01g、黑松露粉0.001-0.01g。
5.根据权利要求4所述的调养五脏和养心安神的配方,其特征在于:所述食用菌混合粉由以下重量原料组成:猴头菇粉1g、蛹虫草粉0.05g、香菇粉0.005g、灰树花粉0.005g、绣球菌粉0.005g、羊肚菌粉0.005g、松茸粉0.005g、黑松露粉0.005g。
6.一种根据权利要求1-5任一项所述的调养五脏和养心安神的配方的制备方法,其特征在于:将山药粉、枸杞粉、茯苓粉、葛根粉、洛神花粉、雪莲培养物、沙棘粉、蛹虫草粉、陈皮粉、阿胶粉、人参水提粉、短梗五加粉、食用菌混合粉充分混合均匀,装袋即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910250934.3A CN109966387A (zh) | 2019-03-29 | 2019-03-29 | 一种调养五脏和养心安神的配方及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910250934.3A CN109966387A (zh) | 2019-03-29 | 2019-03-29 | 一种调养五脏和养心安神的配方及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109966387A true CN109966387A (zh) | 2019-07-05 |
Family
ID=67081801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910250934.3A Withdrawn CN109966387A (zh) | 2019-03-29 | 2019-03-29 | 一种调养五脏和养心安神的配方及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109966387A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111357893A (zh) * | 2020-03-28 | 2020-07-03 | 王嘉 | 一种松露口服液及其制备方法 |
-
2019
- 2019-03-29 CN CN201910250934.3A patent/CN109966387A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111357893A (zh) * | 2020-03-28 | 2020-07-03 | 王嘉 | 一种松露口服液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN102511869B (zh) | 红枣生姜浓浆 | |
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN108936628A (zh) | 一种脑卒中患者食用的特定全营养配方食品及其制备方法 | |
CN105233140A (zh) | 一种短梗五加健脾益胃功能的组合物及其制备方法 | |
KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
CN1742971A (zh) | 砂仁山楂冲剂及其制备工艺 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN108514109A (zh) | 麻醉术后专用型临床营养配方及其制备方法 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN109966387A (zh) | 一种调养五脏和养心安神的配方及制备方法 | |
CN103751762B (zh) | 一种促进肌肤细胞重组并能延缓衰老的产品 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN108095075A (zh) | 流产女性专用型临床营养配方及其制备方法 | |
CN101057650A (zh) | 五行蔬菜制剂 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN103416461A (zh) | 一种防治胃溃疡、十二指肠溃疡的健康食品 | |
CN106234636A (zh) | 一种补血玉米油 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN105250747A (zh) | 一种养生膏 | |
CN111903823A (zh) | 一种代餐食品及其制备方法 | |
CN105105127A (zh) | 一种红果舒心粉多功能保健食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190705 |
|
WW01 | Invention patent application withdrawn after publication |